Skip to content
Their Record

House Roll Call 820, 98th Congress · August 8, 1984

TO AGREE TO H. RES. 569, THE RULE UNDER H.R. 3605 IS TO BE CONSIDERED. H.R. 3605 AMENDS THE FEDERAL FOOD, DRUG, AND COSMETIC ACT TO AUTHORIZE AN ABBREVIATED NEW DRUG APPLICATION UNDER SECTION 505 OF THAT ACT FOR GENERIC NEW DRUGS EQUIVALENT TO APPROVED NEW DRUGS. (MOTION PASSED)

304 yea · 74 nay54 not voting or present
Democrat225 yea · 0 nay
Republican77 yea · 73 nay
Independent1 yea · 0 nay
Other1 yea · 1 nay

Solid = yea, faded = nay.

The measure

H.R. 3605

Drug Price Competition and Patent Term Restoration Act of 1984

Policy area: Health — assigned by Library of Congress subject specialists, not by this site.

How this vote is scored

Which tracked issues this roll call counts toward, and which way a yea vote moves a member on each. Direction is decided per issue, because one bill can push two issues opposite ways.

  • Health CareDirection unreadable — not scored

    excluded:model-unclear (0.95) Procedural vote approving a rule for bill consideration.

    Tagged by: policy-area:Health

    Axis: Expand coverage ← → Restrict coverage

Who voted which way

Every member recorded on this roll call, with the party they sat with at the time.

Yea (304)

Nay (74)

Not voting or present (54)

Vote records come from Voteview (voteview.com); bill titles and policy areas from the congress.gov API. See methodology for how the record was built.